Inactive Instrument
Pandion Therapeutics, Inc. Share Price
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 01/08/2020 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/21 | Tender | Director | 91,738 | 0.3108% | ||
| 01/04/21 | Polaris Growth Management LLC
| Tender | Company | 32,01,422 | 10.8465% | |
| 01/04/21 | Tender | Executive/Senior Manager | 1,89,780 | 0.6430% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 170.43Cr | |
| +0.06% | +7.20% | +54.04% | +111.13% | 7.43TCr | |
| -2.29% | -1.51% | +33.30% | +75.07% | 6.12TCr | |
| +0.28% | +5.73% | +33.67% | +23.80% | 2.75TCr | |
| -2.05% | -3.46% | -18.60% | +352.20% | 2.64TCr | |
| -2.39% | +2.74% | +0.19% | -5.91% | 2.53TCr | |
| +0.57% | +3.66% | +25.59% | -9.37% | 2.08TCr | |
| -1.47% | +4.86% | -5.94% | +513.33% | 1.49TCr | |
| +1.29% | -2.49% | +163.31% | +333.06% | 1.52TCr | |
| -2.44% | -0.09% | +42.50% | +164.11% | 1.44TCr | |
| Average | -0.82% | +2.74% | +36.45% | +173.05% | 3.11TCr | |
| Weighted average by Cap. | -0.95% | +2.69% | +35.80% | +134.01% |
Employees
56
